A Comparative Study Between Anterior and Posterior Pyelotomy in Transperitoneal Laparoscopic Pyelolithotomy
Launched by DAMASCUS UNIVERSITY · Apr 30, 2024
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
This is a randomized controlled clinical trial that aims to collect a sample within two years from the date of approval of the Scientific Research Council at Damascus University.
The study will focus on a group of patients who will undergo a transperitoneal laparoscopic pyelolithotomy surgery.
The patients will be randomly divided into two groups. The first group will undergo a traditional transperitoneal laparoscopic pyelolithotomy, which involves application of anterior pyelotomy.
The second group will receive a modified transperitoneal laparoscopic pyelolithotomy, which involves appli...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with large renal pelvic stone \> 2 cm .
- • failure of minimally invasive approaches such as PCNL or ESWL
- • stones that were neither amenable to ESWL nor were ideally suitable for PCNL
- • Patient's preference for a quick one-stage procedure.
- • Negative urine culture
- Exclusion Criteria:
- • Patients refusing study participation.
- • Contraindication to general anesthesia.
- • Contraindication to laparoscopic surgery.
- • Patients with an intrarenal pelvis.
- • Previous surgical on the same kidney.
- • Associated anatomical deformity.
About Damascus University
Damascus University, a prestigious institution located in Syria, is committed to advancing medical research and healthcare innovation through its clinical trial initiatives. With a focus on fostering collaboration between academia and clinical practice, the university aims to enhance the understanding of various medical conditions and improve patient outcomes. By leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, Damascus University strives to contribute to the global body of knowledge in the medical field and support the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Damascus, , Syrian Arab Republic
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported